XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.8.0.1

12. Stock-based Compensation | 6 Months Ended
--- | ---
Mar. 31, 2018
Share-based Compensation [Abstract] |
Stock-based Compensation | From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period. Stock Options The following table summarizes stock option activity for the six months ended March 31, 2018:
|  |  |  |  | Weighted |  |  | Weighted |  |  |  |
|  |  |  |  | Average |  |  | Average |  |  |  |
|  | Number of |  |  | Exercise |  |  | Remaining |  |  |  |
|  | Shares |  |  | Price |  |  | Contractual Life |  |  | Intrinsic Value |
Outstanding at September 30, 2017 |  |  | 211,668 |  |  | $ | 13.19 |  |  |  | 3.47 |  |  | $ | 454,417 |
Granted |  |  | 20,000 |  |  |  | 32.24 |  |  |  | 10.00 |  |  |  |  |
Exercised |  |  | – |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | – |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at March 31, 2018 |  |  | 231,668 |  |  | $ | 14.84 |  |  |  | 3.54 |  |  | $ | 429,417 |
Exercisable at March 31, 2018 |  |  | 187,167 |  |  | $ | 11.75 |  |  |  | 2.58 |  |  | $ | 429,417 |
The Company recognized compensation expense of $60,829 and $68,084 during the three months ended March 31, 2018 and 2017, respectively. The Company recognized compensation expense of $140,185 and $69,520 during the six months ended March 31, 2018 and 2017, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures. At March 31, 2018, the Company has $385,179 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the company expects to recognize as compensation expense through October of 2022. The exercise price for stock options outstanding and exercisable outstanding at March 31, 2018 is as follows:
Outstanding |  |  | Exercisable |
Number of |  |  | Exercise |  |  | Number of |  |  | Exercise |
Options |  |  | Price |  |  | Options |  |  | Price |
| 31,250 |  |  | $ | 5.00 |  |  |  | 31,250 |  |  | $ | 5.00 |
| 25,000 |  |  |  | 7.50 |  |  |  | 25,000 |  |  |  | 7.50 |
| 31,250 |  |  |  | 10.00 |  |  |  | 31,250 |  |  |  | 10.00 |
| 4,167 |  |  |  | 10.86 |  |  |  | 4,167 |  |  |  | 10.86 |
| 4,167 |  |  |  | 10.86 |  |  |  |  |  |  |  |  |
| 4,167 |  |  |  | 10.86 |  |  |  |  |  |  |  |  |
| 4,167 |  |  |  | 10.86 |  |  |  |  |  |  |  |  |
| 6,250 |  |  |  | 12.50 |  |  |  | 6,250 |  |  |  | 12.50 |
| 6,250 |  |  |  | 15.00 |  |  |  | 6,250 |  |  |  | 15.00 |
| 75,000 |  |  |  | 15.18 |  |  |  | 75,000 |  |  |  | 15.18 |
| 8,000 |  |  |  | 23.41 |  |  |  | 8,000 |  |  |  | 15.18 |
| 8,000 |  |  |  | 27.60 |  |  |  |  |  |  |  |  |
| 8,000 |  |  |  | 31.74 |  |  |  |  |  |  |  |  |
| 8,000 |  |  |  | 36.50 |  |  |  |  |  |  |  |  |
| 8,000 |  |  |  | 41.98 |  |  |  |  |  |  |  |  |
| 231,668 |  |  |  |  |  |  |  | 187,167 |  |  |  |  |
The following table summarizes information about the Company’s non-vested shares outstanding as of March 31, 2018:
|  |  |  |  | Weighted |
|  |  |  |  | Average |
|  | Number of |  |  | Grant-Date |
Non-vested Shares |  | Shares |  |  | Fair Value |
Non-vested at September 30, 2017 |  |  | 36,668 |  |  | $ | 17.70 |
Granted |  |  | 20,000 |  |  | $ | 10.14 |
Vested |  |  | (12,167 | ) |  | $ | 13.32 |
Non-vested at March 31, 2018 |  |  | 44,501 |  |  | $ | 13.54 |
Options were granted during fiscal 2017 and 2016, where the exercise price was less than the common stock price at the date of grant or where the exercise price was greater than the common stock price at the date of grant. There have been no options granted in fiscal 2018 to date. The assumptions used in calculating the fair value of stock options granted use the Black-Scholes option pricing model for options granted were as follows:
Risk-free interest rate |  | 1.25%
Expected life of the options |  | 5.0 to 10.0 years
Expected volatility |  | 107%
Expected dividend yield |  | 0%

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration